vs
shutterstock没有广泛通用的标准中文译名，所以这里是null（SSTK）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
shutterstock没有广泛通用的标准中文译名，所以这里是null的季度营收约是再鼎医药的1.7倍（$220.2M vs $127.1M），再鼎医药同比增速更快（17.1% vs -12.0%），shutterstock没有广泛通用的标准中文译名，所以这里是null自由现金流更多（$25.9M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 1.4%）
Shutterstock是一家总部位于美国纽约的素材服务提供商，由程序员兼摄影师乔恩·奥林格于2002年创立。平台拥有约2亿张免版税的图片、矢量图与插画素材，另有超千万条视频剪辑和音乐曲目可供授权使用，同时也为用户提供编辑工具服务，业务模式已从最初仅支持订阅拓展出单点购买选项。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
SSTK vs ZLAB — 直观对比
营收规模更大
SSTK
是对方的1.7倍
$127.1M
营收增速更快
ZLAB
高出29.1%
-12.0%
自由现金流更多
SSTK
多$52.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $220.2M | $127.1M |
| 净利润 | $-16.0M | — |
| 毛利率 | 55.8% | 51.0% |
| 营业利润率 | -1.1% | -54.6% |
| 净利率 | -7.3% | — |
| 营收同比 | -12.0% | 17.1% |
| 净利润同比 | -1021.0% | — |
| 每股收益（稀释后） | $-0.47 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SSTKZLAB
| Q4 25 | $220.2M | $127.1M | ||
| Q3 25 | $260.1M | $115.4M | ||
| Q2 25 | $267.0M | $109.1M | ||
| Q1 25 | $242.6M | $105.7M | ||
| Q4 24 | $250.3M | $108.5M | ||
| Q3 24 | $250.6M | $101.8M | ||
| Q2 24 | $220.1M | $100.1M | ||
| Q1 24 | $214.3M | $87.1M |
净利润SSTKZLAB
| Q4 25 | $-16.0M | — | ||
| Q3 25 | $13.4M | $-36.0M | ||
| Q2 25 | $29.4M | $-40.7M | ||
| Q1 25 | $18.7M | $-48.4M | ||
| Q4 24 | $-1.4M | — | ||
| Q3 24 | $17.6M | $-41.7M | ||
| Q2 24 | $3.6M | $-80.3M | ||
| Q1 24 | $16.1M | $-53.5M |
毛利率SSTKZLAB
| Q4 25 | 55.8% | 51.0% | ||
| Q3 25 | 60.6% | 59.5% | ||
| Q2 25 | 60.3% | 60.6% | ||
| Q1 25 | 58.4% | 63.6% | ||
| Q4 24 | 55.1% | 61.5% | ||
| Q3 24 | 58.3% | 64.1% | ||
| Q2 24 | 58.5% | 64.9% | ||
| Q1 24 | 58.8% | 61.4% |
营业利润率SSTKZLAB
| Q4 25 | -1.1% | -54.6% | ||
| Q3 25 | 12.5% | -42.3% | ||
| Q2 25 | 13.0% | -50.3% | ||
| Q1 25 | 4.2% | -53.3% | ||
| Q4 24 | 5.3% | -62.6% | ||
| Q3 24 | 7.2% | -66.6% | ||
| Q2 24 | 9.4% | -76.0% | ||
| Q1 24 | 7.8% | -80.7% |
净利率SSTKZLAB
| Q4 25 | -7.3% | — | ||
| Q3 25 | 5.1% | -31.2% | ||
| Q2 25 | 11.0% | -37.3% | ||
| Q1 25 | 7.7% | -45.8% | ||
| Q4 24 | -0.6% | — | ||
| Q3 24 | 7.0% | -40.9% | ||
| Q2 24 | 1.6% | -80.2% | ||
| Q1 24 | 7.5% | -61.4% |
每股收益（稀释后）SSTKZLAB
| Q4 25 | $-0.47 | $-0.05 | ||
| Q3 25 | $0.37 | $-0.03 | ||
| Q2 25 | $0.82 | $-0.04 | ||
| Q1 25 | $0.53 | $-0.04 | ||
| Q4 24 | $-0.04 | $-0.09 | ||
| Q3 24 | $0.50 | $-0.04 | ||
| Q2 24 | $0.10 | $-0.08 | ||
| Q1 24 | $0.45 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $178.2M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $581.0M | $715.5M |
| 总资产 | $1.4B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SSTKZLAB
| Q4 25 | $178.2M | $689.6M | ||
| Q3 25 | $165.5M | $717.2M | ||
| Q2 25 | $116.4M | $732.2M | ||
| Q1 25 | $112.2M | $757.3M | ||
| Q4 24 | $111.3M | $779.7M | ||
| Q3 24 | $131.4M | $616.1M | ||
| Q2 24 | $74.9M | $630.0M | ||
| Q1 24 | $71.8M | $650.8M |
股东权益SSTKZLAB
| Q4 25 | $581.0M | $715.5M | ||
| Q3 25 | $594.4M | $759.9M | ||
| Q2 25 | $586.2M | $791.7M | ||
| Q1 25 | $547.2M | $810.8M | ||
| Q4 24 | $518.4M | $840.9M | ||
| Q3 24 | $522.9M | $667.7M | ||
| Q2 24 | $520.4M | $704.2M | ||
| Q1 24 | $541.3M | $762.2M |
总资产SSTKZLAB
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.3B | $985.3M | ||
| Q2 24 | $1.0B | $987.4M | ||
| Q1 24 | $1.0B | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.2M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $25.9M | $-26.7M |
| 自由现金流率自由现金流/营收 | 11.8% | -21.0% |
| 资本支出强度资本支出/营收 | 4.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $123.8M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流SSTKZLAB
| Q4 25 | $36.2M | $-26.0M | ||
| Q3 25 | $78.4M | $-32.0M | ||
| Q2 25 | $26.8M | $-31.0M | ||
| Q1 25 | $25.2M | $-61.7M | ||
| Q4 24 | $8.0M | $-55.8M | ||
| Q3 24 | $-11.6M | $-26.8M | ||
| Q2 24 | $28.0M | $-42.2M | ||
| Q1 24 | $8.3M | $-90.1M |
自由现金流SSTKZLAB
| Q4 25 | $25.9M | $-26.7M | ||
| Q3 25 | $68.0M | $-35.0M | ||
| Q2 25 | $15.5M | $-33.9M | ||
| Q1 25 | $14.4M | $-63.2M | ||
| Q4 24 | $-952.0K | $-58.4M | ||
| Q3 24 | $-26.3M | $-28.2M | ||
| Q2 24 | $18.9M | $-42.9M | ||
| Q1 24 | $-6.2M | $-91.1M |
自由现金流率SSTKZLAB
| Q4 25 | 11.8% | -21.0% | ||
| Q3 25 | 26.1% | -30.4% | ||
| Q2 25 | 5.8% | -31.1% | ||
| Q1 25 | 6.0% | -59.9% | ||
| Q4 24 | -0.4% | -53.8% | ||
| Q3 24 | -10.5% | -27.7% | ||
| Q2 24 | 8.6% | -42.9% | ||
| Q1 24 | -2.9% | -104.5% |
资本支出强度SSTKZLAB
| Q4 25 | 4.7% | 0.5% | ||
| Q3 25 | 4.0% | 2.6% | ||
| Q2 25 | 4.2% | 2.6% | ||
| Q1 25 | 4.5% | 1.5% | ||
| Q4 24 | 3.6% | 2.4% | ||
| Q3 24 | 5.9% | 1.3% | ||
| Q2 24 | 4.1% | 0.7% | ||
| Q1 24 | 6.7% | 1.1% |
现金转化率SSTKZLAB
| Q4 25 | — | — | ||
| Q3 25 | 5.86× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 1.35× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.66× | — | ||
| Q2 24 | 7.71× | — | ||
| Q1 24 | 0.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SSTK
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
